ChongQing Zhengchuan Pharmaceutical Packaging Co.,Ltd (SHA:603976)
China flag China · Delayed Price · Currency is CNY
21.62
-0.30 (-1.37%)
May 28, 2026, 3:00 PM CST

SHA:603976 Income Statement

Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Mar '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Operating Revenue
709.31662.26797.8896.9793.01793.62
Other Revenue
2.122.123.333.743.193.04
711.43664.37801.12900.65796.2796.66
Revenue Growth (YoY)
-0.78%-17.07%-11.05%13.12%-0.06%58.70%
Cost of Revenue
600.36556.42655.95759.02642.95598.3
Gross Profit
111.07107.95145.18141.63153.25198.36
Selling, General & Admin
56.0655.3655.5157.1357.4658.93
Research & Development
13.8814.5120.2623.4319.1112.08
Other Operating Expenses
12.58.860.029.329.549.22
Operating Expenses
88.381.6975.590.7686.7381.82
Operating Income
22.7726.2669.6750.8766.52116.54
Interest Expense
-21.48-21.31-20.95-21.26-19.61-13.08
Interest & Investment Income
8.098.79.89.178.399.12
Currency Exchange Gain (Loss)
0.280.280.07-0.25-0.040.73
Other Non Operating Income (Expenses)
0.6-0.06-0.04-0.04-0.060.05
EBT Excluding Unusual Items
10.2613.8758.5638.4955.2113.37
Gain (Loss) on Sale of Investments
-0.22-0.050.471.05-0.944.76
Gain (Loss) on Sale of Assets
-0.73-0.83-5.3-0.19-1.32-0.53
Asset Writedown
-2.83-----
Legal Settlements
------1.87
Other Unusual Items
8.717.056.495.475.6110.25
Pretax Income
15.1920.0460.2144.8358.55125.97
Income Tax Expense
0.371.146.964.56-6.2219.37
Net Income
14.8218.953.2540.2764.77106.6
Net Income to Common
14.8218.953.2540.2764.77106.6
Net Income Growth
-65.63%-64.50%32.24%-37.83%-39.24%100.95%
Shares Outstanding (Basic)
141145152149151150
Shares Outstanding (Diluted)
141145152149151150
Shares Change (YoY)
-8.44%-4.42%2.01%-0.99%0.32%-0.94%
EPS (Basic)
0.110.130.350.270.430.71
EPS (Diluted)
0.110.130.350.270.430.71
EPS Growth
-62.47%-62.86%29.63%-37.21%-39.44%102.86%
Free Cash Flow
126.63109.3840.2104.22-237.66-32.58
Free Cash Flow Per Share
0.900.750.260.70-1.58-0.22
Dividend Per Share
0.2900.2900.3460.2000.0600.308
Dividend Growth
-16.18%-16.18%73.00%233.33%-80.52%755.56%
Gross Margin
15.61%16.25%18.12%15.72%19.25%24.90%
Operating Margin
3.20%3.95%8.70%5.65%8.35%14.63%
Profit Margin
2.08%2.84%6.65%4.47%8.13%13.38%
Free Cash Flow Margin
17.80%16.46%5.02%11.57%-29.85%-4.09%
EBITDA
-132.68184.06156.3152.62182.98
EBITDA Margin
-19.97%22.98%17.36%19.17%22.97%
D&A For EBITDA
-106.42114.39105.4386.1166.45
EBIT
22.7726.2669.6750.8766.52116.54
EBIT Margin
3.20%3.95%8.70%5.65%8.35%14.63%
Effective Tax Rate
2.46%5.68%11.56%10.17%-15.38%
Revenue as Reported
711.43664.37801.12900.65796.2796.66
Advertising Expenses
-1.221.05-0.62.02
Source: S&P Global Market Intelligence. Standard template. Financial Sources.